Royalty Pharmaplc Stock Today
| RPRX Stock | USD 27.98 0.16 0.58% |
Performance0 of 100
| Odds Of DistressLess than 5
|
Royalty PharmaPlc is trading at 27.98 as of the 25th of April 2024; that is 0.58 percent up since the beginning of the trading day. The stock's open price was 27.82. Royalty PharmaPlc has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Equity ratings for Royalty PharmaPlc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of March 1993 | Category Healthcare | Classification Health Care |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. The company was founded in 1996 and is based in New York, New York. Royalty Pharma is traded on NASDAQ Exchange in the United States.. The company has 446.69 M outstanding shares of which 12.39 M shares are at this time shorted by private and institutional investors with about 5.11 trading days to cover. More on Royalty PharmaPlc
Moving together with Royalty Stock
| 0.61 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
Moving against Royalty Stock
| 0.5 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.45 | ELYM | Eliem Therapeutics | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Royalty Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Royalty PharmaPlc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Royalty PharmaPlc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Joseph Podolski | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Biotechnology, ARCA Pharmaceutical, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Royalty PharmaPlc report their recommendations after researching Royalty PharmaPlc's financial statements, talking to executives and customers, or listening in on Royalty PharmaPlc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Royalty PharmaPlc. The Royalty consensus assessment is calculated by taking the average forecast from all of the analysts covering Royalty PharmaPlc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Royalty PharmaPlc's historical financial statements, Royalty PharmaPlc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Royalty PharmaPlc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Royalty PharmaPlc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Royalty PharmaPlc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Royalty PharmaPlc's financial leverage. It provides some insight into what part of Royalty PharmaPlc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Royalty PharmaPlc (RPRX) is traded on NASDAQ Exchange in USA. It is located in 110 East 59th Street, New York, NY, United States, 10022 and employs 24 people. Royalty PharmaPlc is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Royalty PharmaPlc's market, we take the total number of its shares issued and multiply it by Royalty PharmaPlc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Royalty PharmaPlc conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 446.69 M outstanding shares of which 12.39 M shares are at this time shorted by private and institutional investors with about 5.11 trading days to cover.
Royalty PharmaPlc currently holds about 1.47 B in cash with 3.03 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Check Royalty PharmaPlc Probability Of Bankruptcy
Ownership AllocationRoyalty PharmaPlc has a total of 446.69 Million outstanding shares. The majority of Royalty PharmaPlc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Royalty PharmaPlc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Royalty PharmaPlc. Please pay attention to any change in the institutional holdings of Royalty PharmaPlc as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Royalty Ownership Details
Royalty Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Royalty PharmaPlc jumping above the current price in 90 days from now is about 92.99%. The Royalty PharmaPlc probability density function shows the probability of Royalty PharmaPlc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Royalty PharmaPlc has a beta of 0.5602 indicating as returns on the market go up, Royalty PharmaPlc average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Royalty PharmaPlc will be expected to be much smaller as well. Additionally, royalty PharmaPlc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Royalty PharmaPlc to move above the current price in 90 days from now is about 92.99 (This Royalty PharmaPlc probability density function shows the probability of Royalty Stock to fall within a particular range of prices over 90 days) .
Royalty Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Royalty PharmaPlc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Royalty PharmaPlc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Royalty PharmaPlc's value.| Instituion | Recorded On | Shares | |
| Unisphere Establishment | 2023-12-31 | 5 M | |
| Norges Bank | 2023-12-31 | 4.3 M | |
| Suvretta Capital Management, Llc | 2023-12-31 | 3.9 M | |
| Amundi | 2023-12-31 | 3.7 M | |
| Siguler Guff Advisers, Llc | 2023-12-31 | 3.4 M | |
| Legal & General Group Plc | 2023-12-31 | 2.9 M | |
| Northern Trust Corp | 2023-12-31 | 2.6 M | |
| Man Group Plc | 2023-12-31 | 2.6 M | |
| California Public Employees Retrmnt Sys | 2023-12-31 | 2.1 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 46.4 M | |
| Vanguard Group Inc | 2023-12-31 | 38 M |
Royalty PharmaPlc Historical Income Statement
Royalty PharmaPlc Income Statement is one of the three primary financial statements used for reporting Royalty's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Royalty PharmaPlc revenue and expense. Royalty PharmaPlc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Royalty PharmaPlc's Interest Expense is fairly stable compared to the past year. Total Revenue is likely to rise to about 2.5 B in 2024, whereas Gross Profit is likely to drop slightly above 1.4 B in 2024. View More FundamentalsRoyalty Stock Against Markets
Picking the right benchmark for Royalty PharmaPlc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Royalty PharmaPlc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Royalty PharmaPlc is critical whether you are bullish or bearish towards Royalty PharmaPlc at a given time. Please also check how Royalty PharmaPlc's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Royalty PharmaPlc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Royalty PharmaPlc Corporate Management
Elected by the shareholders, the Royalty PharmaPlc's board of directors comprises two types of representatives: Royalty PharmaPlc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Royalty. The board's role is to monitor Royalty PharmaPlc's management team and ensure that shareholders' interests are well served. Royalty PharmaPlc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Royalty PharmaPlc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eric Schneider | Senior Officer | Profile | |
| George Lloyd | Executive Officer | Profile | |
| Marshall MD | Executive Investments | Profile | |
| Sandy Balkin | Senior Analytics | Profile |
How to buy Royalty Stock?
Before investing in Royalty PharmaPlc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Royalty PharmaPlc. To buy Royalty PharmaPlc stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Royalty PharmaPlc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Royalty PharmaPlc stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Royalty PharmaPlc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Royalty PharmaPlc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Royalty PharmaPlc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Royalty Stock please use our How to Invest in Royalty PharmaPlc guide.
Already Invested in Royalty PharmaPlc?
The danger of trading Royalty PharmaPlc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Royalty PharmaPlc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Royalty PharmaPlc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Royalty PharmaPlc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Royalty PharmaPlc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Royalty PharmaPlc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Royalty Pharmaplc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Royalty Pharmaplc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty PharmaPlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Royalty Stock please use our How to Invest in Royalty PharmaPlc guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Royalty Stock analysis
When running Royalty PharmaPlc's price analysis, check to measure Royalty PharmaPlc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty PharmaPlc is operating at the current time. Most of Royalty PharmaPlc's value examination focuses on studying past and present price action to predict the probability of Royalty PharmaPlc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty PharmaPlc's price. Additionally, you may evaluate how the addition of Royalty PharmaPlc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Royalty PharmaPlc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Royalty PharmaPlc. If investors know Royalty will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Royalty PharmaPlc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Dividend Share 0.8 | Earnings Share 2.53 | Revenue Per Share 5.26 | Quarterly Revenue Growth 0.054 |
The market value of Royalty PharmaPlc is measured differently than its book value, which is the value of Royalty that is recorded on the company's balance sheet. Investors also form their own opinion of Royalty PharmaPlc's value that differs from its market value or its book value, called intrinsic value, which is Royalty PharmaPlc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Royalty PharmaPlc's market value can be influenced by many factors that don't directly affect Royalty PharmaPlc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Royalty PharmaPlc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Royalty PharmaPlc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Royalty PharmaPlc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.